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Nanoflow-HPLC-tandem mass spectrometry (MS/MS) was used to analyze the peptide
fraction of breast milk samples collected from a single non-atopic donor on different
days (10 samples) after receiving an oral load of cow’s milk (by drinking 200mL of bovine
milk). In addition, breast milk was sampled from the same lactating mother over a 6-h
period at five time points after drinking cow’s milk. We aimed to trace the intra-individual
variability and to define a time profile of the excretion of dietary peptides into breast
milk. Overall, 21 peptides exclusively originating from both bovine caseins and whey
proteins with no match within the human milk proteome were identified in the breast milk
samples. These peptides were missing in the breast milk obtained from the mother after a
prolongedmilk- and dairy-free diet (three samples). The time course of cow’smilk-derived
β-Lg f(125–135) and β-casein f(81–92) in breast milk was determined from the MS ion
intensity of the peptide signals. No intact cow’s milk gene products were detected
by HPLC-MS/MS analysis and Western blotting with anti-β-Lg antibody, but dot-blot
analysis confirmed the occurrence of β-Lg fragments in the enriched peptide fraction of
breast milk. These data suggest shifting the analytical perspective for the detection of
dietary food allergens in breast milk from intact proteins to digested peptide fragments.
The possible sensitization and elicitation potential or the tolerogenic properties of such
low amounts of dietary peptides for the breastfed newborns remain to be explored.
Keywords: breast milk, cow’s milk proteins, food allergens, protein digestion, HPLC-MS/MS, Western blot,
β-lactoglobulin, breastfeeding
INTRODUCTION
Breast milk contains antigenically active food allergens arising from the mother’s diet (1). This
assertion is mainly based on immunochemical data and clinical investigations carried out in the
1980s and 90s (4–6). In those years, it had been clearly established that food allergens derived
from a mother’s diet can elicit clinical manifestations of adverse reactions in exclusively breastfed
susceptible newborns, with an incidence rate of 0.5% (7–10). Several studies have documented the
presence of variable amounts of intact food allergens in breast milk, including ovalbumin (11),
gliadin (12), peanut (2, 13), and cow’s milk proteins (10). Food allergens in human milk have been
reported to vary over a very wide range of concentrations from just above 0.1 to>1,000 ng/mL (3),
but low ppb (ng/mL) levels are probably the most realistic figures (14).
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The search for cow’s milk allergens in breast milk has been
the subject of fervent research. Human and bovine β-casein, αs1-
casein, and α-lactalbumin share a medium to high degree of
sequence homology (53, 31, and 73% homology, respectively)
and, hence, a certain immune cross-reactivity. Therefore, β-
lactoglobulin (β-Lg), which is not expressed by humans, has
often been monitored as a cow’s milk marker. According to
immunochemical data, the excretion of dietary food allergens
into breast milk generally appears to be affected by marked
inter- and intra-individual variability (11, 14–16). With specific
concern to cow’s milk allergens, exogenous β-Lg has been
detected in only a limited number of mothers’ milk samples,
and its presence is not related to atopic or non-atopic conditions
(15). In a longitudinal study carried out over the entire lactation
period, 93 out of 232 (i.e., 40%) breast milk samples obtained
from 25 healthy donors contained a detectable amount of dietary
β-Lg (16). Only two mothers had detectable β-Lg in all their milk
samples, while the milk of six mothers did not contain it on
any occasion. Recently, Matangkasombut et al. (17) reported that
dietary β-Lg was persistent in human milk even up to 7 days after
the consumption of cow’s milk.
In spite of the bulk of research carried out in regard to this
topic, the evidence about dietary allergens in breast milk remains
controversial, primarily because the immunochemical methods
could be biased from a series of pitfalls related to the antibody
recognition of the protein targets and to matrix interference
effects. More recently, a few studies have attempted to detect
dietary proteins in breast milk with antibody-independent
methods. β-Lg in human milk should definitely be considered
an artifact due to non-specific antibody cross-reactivity with
endogenous human milk proteins (18, 19). However, intact
bovine αs1-casein of dietary origin has also been detected in
human milk (20) and colostrum (21) with mass spectrometry
(MS)-based proteomics. Nevertheless, these findings appear to
conflict with the latest observations obtained in vivo, which
suggest that β-Lg might be partially intact even at level of
the mother’s intestine, whereas caseins are completely degraded
in the upper gastrointestinal tract (22). On the other hand, it
remains to be established whether intact or partially hydrolyzed
dietary antigens could be taken up and then excreted into
breast milk through routes other than the intestinal one. Such
a possibility is supported by the very quick appearance of
peanut allergens in breast milk, even within a few minutes after
ingestion (13).
Schocker et al. (23) exploited two-dimensional
electrophoresis/Western blot and MS to investigate the
passage of unhydrolyzed Ara h 2 and other peanut allergens
into breast milk. Interestingly, they also assayed human milk
samples with competitive ELISA in order to quantify possible
digestion-resistant peptides derived from peanut proteins.
For the first time, we exploited MS to detect peptides
arising from the digestion of bovine casein and whey proteins
excreted into the breast milk of lactating donors after an
oral administration of cow’s milk (24). In particular, bovine
β-Lg and αs1-casein fragments were detected in the 12%
trichloroacetic (TCA)-soluble fraction of two and one out
six breast milk samples, respectively. In contrast, the β-Lg
peptides identified by high-resolution/sensitivity MS escaped
the competitive ELISA test performed on unfractionated milk,
suggesting that they might occur with very low abundance.
As expected, control milk samples obtained from six lactating
women complying with strict milk- and diary-free diet were
lacking cow’s milk-derived peptides. The absence of intact β-Lg at
detectable amounts in any breast milk samples was confirmed by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and Western blot analysis of the 12% TCA-insoluble
protein pellet. Very recently, Zhu at al. (25) obtained a highly
curated inventory of non-human peptides in human milk based
on MS data, and cow’s milk-derived peptides were the most
represented species.
In this study, we aimed to monitor the possible intra-
individual variability of dietary cow’s milk peptides in human
milk. For this purpose, we targeted bovine milk-derived peptides
in breast milk sampled from a single donor before and after
opportune oral cow’s milk loads on different days. In addition,
breast milk was sampled from the same lactating mother over a
6-h period (five time points) after drinking cow’s milk. Janssen
Duijghuijsen et al. (26) elegantly highlighted the possibility that
food-derived peptides of varying length might be caught by
endogenous antibodies in body fluids. Thus, in addition to the
12% TCA-soluble fraction, we analyzed the tryptic digests of the
insoluble protein pellet using HPLC-MS/MS.
MATERIALS AND METHODS
Ditiothreitol (DTT), iodoacetamide (IAA), guanidine,
trifluoroacetic acid (TFA), ammonium bicarbonate (Ambic),
Tris-base, EDTA, and other chemicals were purchased from
Sigma-Aldrich (St. Louis, MI, USA). HPLC-MS-grade solvents
were obtained from Carlo Erba (Milan, Italy). The bovine
milk whey protein isolate used for the preparation of positive
controls was obtained from Fonterra Dairy Co. via the Riddett
Institute, New Zealand.
Sampling
A total of 18 breast milk samples (5mL) were obtained through
a breast pump equipped with plastic disposable pump sets. The
samples were collected during the second and third month
of lactation after parturition from a non-atopic healthy donor
(28 years old) who delivered at term. Breast milk samples
(∼5mL) were collected over different days between 2 and 3 h
after a 200-mL oral load of pasteurized bovine milk. Milk was
expressed into plastic sterile tubes, mixed with a serine-protease
inhibitor (Pefabloc R©, Sigma, St. Louis, MI, USA, 1mM final
concentration), and immediately frozen at −20◦C to prevent
undesired hydrolysis.
An initial screening was performed on the breast milk samples
collected from the donor over 5 different days. These samples
were designated as D1, D2, D3, D4, and D5. The lactating mother
complied with a strict diet that was free of cow’smilk and dairy for
at least 1 week. Overall, 10 samples were obtained and analyzed
individually by collecting breast milk before and after feeding the
baby on each sampling day. Samples of the D series were run in
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duplicate. Three control milk samples (baselines) were collected
before the mother was given cow’s milk.
After assessing the presence of bovine milk-derived peptides
in breast milk, additional samples were obtained from the same
mother. In this case, breast milk was collected over a 6-h period at
time intervals (1, 2, 3, 4, and 6 h) following an oral load of bovine
milk. These samples are designed as T0 (baseline), T1 (1 h), T2
(2 h), T3 (3 h), T4 (4 h), and T5 (6 h) and were analyzed with
HPLC-MS/MS in triplicate. A skilled operator at the Department
of Translational Medicine of the University of Naples “Federico
II” (Italy) supervised the administration of bovine milk, sample
collection, and code labeling. Prior to collecting milk samples,
written informed consent was obtained from the mother.
Peptide Extraction
Aliquots of breast milk samples were skimmed by centrifugation
(3,000 × g for 15min at 4◦C), and the upper fat layer was
removed with a spatula (which was repeated twice). The proteins
of the skimmed milk were precipitated at 4◦C with a final
concentration of 12% (w/v) trichloroacetic acid (TCA) and
pelleted by centrifugation (4,500 × g for 30min at 4◦C). The
12% TCA soluble peptides (250 µL) were solid-phase extracted
using C18 reverse-phase spin columns (Pierce Biotechnology,
Rockford, IL, USA), extensively washed with 0.1% trifluoroacetic
acid (TFA), and eluted with 70% acetonitrile (AcN) containing
0.1% TFA. AcN was evaporated in a SpeedVac
TM
Evaporator
System, and peptides were finally lyophilized.
Tryptic Hydrolysis of the Protein Pellet
In order to remove TCA from the residual pellet, the precipitate
was re-suspended in cold acetone (−20◦C) and centrifuged at
4,500× g for 30min at 4◦C three times. Finally, 5mg of the dried
protein powder was dissolved in 1mL of a denaturing/reducing
buffer (6M guanidine HCl, 0.3M Tris, 1mM EDTA, 10mM
DTT, pH 8.0) and incubated at 56◦C for 1 h. Afterwards, cysteines
were alkylated with IAA (55mM final concentration) for 40min
at room temperature in the dark. DTT in a stoichiometric
amount was used to quench the IAA excess. The Cys-alkylated
proteins (50 µL aliquots) were diluted 10-fold with 25mM
ammonium bicarbonate (AMBIC) at pH 7.8 and digested
overnight at 37◦C with trypsin at an enzyme-to-substrate ratio
of 1:50 (w:w). The resulting peptides were purified using C18
reverse-phase spin columns and lyophilized prior to HPLC-
MS/MS analysis.
Competitive ELISA for β-Lg Fragments
Possible β-Lg-derived peptides in breast milk were assayed
using the RIDASCREEN R© competitive ELISA kit, which was
specifically validated for the detection of hydrolyzed fragments of
β-Lg (R4901, R-Biopharm AG, Darmstadt, Germany). The assay
was carried out according to the manufacturer’s instructions
using intact bovine β-Lg as a standard. Samples were assayed
in duplicate. The standard points fit a cubic spline curve that
was built using the software Ridasoft Win version 1.91 (R-
BiopharmAG). Unfractionated skimmed breast milk was assayed
at two dilutions of 1:500 (recommended by the manufacturer)
and 1:200 (v:v). To exclude matrix effects, control breast milk
samples spiked with variable amounts of β-Lg were used as the
positive control. The limit of detection and limit of quantification
declared by the manufacturer were 2.1 and 5 ppm, respectively,
with<1% cross-reactivity with caseins or other whey proteins.
Dot-Blot and Western Blotting Detection of
Hydrolyzed or Intact β-Lactoglobulin
Peptides in the 12% TCA-soluble fraction of the D-series
breast milk samples were enriched and purified using C18
cartridges as described above. The 70% AcN/0.1% TFA eluate
was dried in a SpeedVac apparatus, re-dissolved in 2 µL of
deionized water, and entirely loaded onto a 0.22-µm-pore-size
nitrocellulose membrane (Bio-Rad, Milan, Italy) for dot-blot
analysis. A chymotryptic digest (1 µg) of bovine milk whey
proteins dissolved in water was obtained by overnight incubation
in 25mM AMBIC at pH 7.8 and 37◦C with proteomic grade
chymotrypsin (Sigma) at an enzyme-to-substrate ratio of 1:50
and used as the positive control.
The 12%TCA-insoluble breast milk proteins washed with cold
acetone at −20◦C were assayed for intact β-Lg by Western blot
analysis. Proteins were dissolved in Laemmli sample buffer at 1
mg/mL, and 10-µg aliquots were separated by SDS-PAGE using
15% acrylamide hand-cast gels (Bio-Rad Laboratories, Hercules,
CA, USA). Bovine whey protein isolate was used as the positive
control at approximate amounts of 2 µg or 20 pg of β-Lg for
the SDS-PAGE and Western blot analyses, respectively. Gels
were run in duplicate; after separation, one gel was stained
using G-250 Coomassie Blue Silver staining, while the other
was electroblotted onto the nitrocellulose membrane using a
Trans-Blot Cell (BioRad) at 400mA and 4◦C for 1 h.
For both dot-blot and Western blotting analyses, membranes
were blocked for 1 h at room temperature with 5% (w/v)
bovine serum albumin (Sigma) in Tris-buffered saline solution
with 0.05% Tween 20 (TBS-T) and incubated overnight at
4◦C with immunoaffinity purified anti-β-Lg IgG polyclonal
antibody developed in rabbit (Abcam Ltd., Cambridge, UK) at
1:10000 dilution in TBS-T. Monoclonal peroxidase-conjugated
mouse anti-rabbit IgG antibody (Sigma) diluted to 1:10000
in TBS-T was applied to the membrane for 1 h at room
temperature. The membrane was extensively rinsed with TBS-
T (3 × 10min) and finally with TBS (1 × 10min) before
development. Chemiluminescence reagents (ECL Plus WB
reagent, GE Healthcare) and X-ray film (Kodak, Chalons/Saône,
France) were used to visualize the immunoreactive peptide spots
or protein bands with exposure times varying in the range
of 0.5–2 min.
HPLC-Orbitrap MS/MS
HPLC-MS/MS analyses were performed using an Ultimate
3,000 nano-flow ultra-high-performance liquid chromatography
(Dionex/Thermo Scientific, San Jose, CA, USA) coupled to a
Q-Exactive Orbitrap mass spectrometer (Thermo Scientific).
Tryptic peptides were reconstituted in 2% AcN/0.1% formic acid,
and nearly 2 µg were loaded through Acclaim PepMap 100 trap
columns (75-µm i.d.× 2 cm; Thermo Scientific) using a FAMOS
autosampler (Thermo Scientific). Peptides were separated using
an EASY-Spray
TM
PepMap C18 column (2µm, 25 cm × 75µm)
with 2-µmparticles and 100-Å pore size (Thermo Scientific). The
separation was done with a 2–50% gradient of B over 120min
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after 5min of isocratic elution at 2% B and a constant flow rate
of 300 nL/min. Eluent A was 0.1% formic acid (v/v) in LC-MS-
grade water, and eluent B was 0.1% formic acid (v/v) in AcN.
MS1 precursor spectra were acquired in the positive ionization
mode scanning the 1,800–300 m/z range with resolving power
of 70,000 full width at half maximum (FWHM), an automatic
gain control (AGC) target of 1 × 106 ions, and maximum ion
injection time of 256ms. The spectrometer operated in full scan
MS1 and data-dependent acquisition mode, selecting up to the
10 most intense ions for MS/MS fragmentation and applying a
12-s dynamic exclusion. Fragmentation spectra were obtained
at a resolving power of 17,500 FWHM. Ions with one charge
or more than six were excluded from the MS/MS selection.
Spectra were elaborated using the software Xcalibur version 3.1
(Thermo Scientific). The MS signal intensity of selected peptides
was determined by integrating the area under the peaks after
an extracted ion process from the total ion current (TIC) full
scan chromatogram.
Database Search and
Peptide Identification
LC-MS/MS raw data were analyzed with the Andromeda tool
of the MaxQuant software package (version 1.6.2.10). The
searches were taxonomically restricted to Homo sapiens and
Bos taurus in the Uniprot database (updated in November
2017). Subsequently, the searches were refined using a manually
constructed protein database containing the 30 most abundant
cow-milk gene products inferred from proteomic-based
investigations (27, 28). For the analysis of 12% TCA-
soluble peptides, the search conditions included unspecific
cleavage, no static modification, Met oxidation, pyroglutamic
acid at N-terminus Gln, and Ser/Thr phosphorylation as
variable modifications.
For the analysis of the protein pellets, trypsin was selected
as the proteolytic enzyme with up to two missed cleavages, and
carbamidomethyl-cysteine was included as a static modification.
The analysis of peptides from the pellet was also repeated under
conditions of non-specific cleavage in order to identify possible
bovine milk-derived peptides arising from the mother’s digestion
and associated with breast milk antibodies. In all cases, the mass
tolerance value was 5 ppm for the precursor ion and 10 ppm
for MS/MS fragments. Peptide Spectrum Matches (PSMs) were
filtered using the target decoy database approach with an e value
of 0.01 peptide-level false discovery rate (FDR), corresponding to
a 99% confidence score. Since there is significant overlap between
human and bovine milk protein sequences, it was necessary
to refine the data further by identifying peptides that matched
both proteomes. Peptides that were an exact match to both a
bovine and a human sequence were removed from the final list
of results. Only peptides originating from the relatively abundant
bovine milk proteins were included in the list of identified
bovine peptides.
RESULTS
Due to an intense activity of endogenous proteases, human
milk is intrinsically rich in oligopeptides (29), which interfere
with the MS-based detection of trace amounts of possible
foreign peptides arising from the mother’s diet. Although the
search for cow’s milk-derived peptides is practically restricted
to relatively few abundant proteins (casein and major whey
proteins), there is no option to predict which peptides might be
excreted into breast milk due to the substantial lack of cleavage
specificity for protein degradation during the pre- and post-
absorptive phases in the mother’s body. Thus, the analytical
complexity of the system requires a combination of “deep”
and “untargeted” peptidomics that can be addressed only using
state-of-art advanced peptidomic approaches. Such a complexity
would also provide a plausible reason for why little or no attempts
have been made to detect food allergen-derived peptides in
human milk so far.
Dietary Cow’s Milk Peptides in Breast Milk
On average, more than 1,200 peptides derived from endogenous
proteins were identified by HPLC-MS/MS in the 12% TCA-
soluble peptide fraction of each breast milk sample (not shown),
as already reported in our previous work (24). However, the
repertory of the endogenous peptides exhibited a significant
intra-individual variability, as clearly observed when comparing
the chromatographic profiles. As expected, most of these
peptides were hydrolytic fragments of human β-casein and
other caseins, while only a few of them were derived from α-
lactalbumin, which is the most abundant protein of mature
human milk. In fact, α-lactalbumin is relatively resistant to
proteolysis under the chemical conditions of milk because of
the compact folding in comparison to the looser structure of
caseins. In contrast, a significantly high number of peptides arose
from human lactoferrin, osteopontin, butyrophilin, lactadherin,
and polymeric-Ig-receptor (24). Since we were interested in
identifying peptides of dietary origin, we refined our search using
a database containing the 30 most abundant cow-milk gene
products. Considering the D1–D5 samples and excluding the
exact sequence matches between bovine and human species, 21
peptides were exclusive products of the bovine milk proteins,
while they had no counterpart within the human milk proteome
(Table 1). In terms of the presence of cow’s milk peptides,
the pairs of samples collected before and after baby feeding
were practically undistinguishable. For this reason, the pairs
of D1–D5 samples were not designed with different labels.
Thus, for example, in Table 1, D1 collectively designates the
breast milk samples obtained on the first collection day
either before or after feeding the baby. Cow’s milk peptides
excreted into breast milk were chiefly from β-casein and β-
Lg, although traces of other caseins (αs1- and κ-casein) and
lactoferrin were identified at a very high degree of confidence
as well (FDR 1%, p<< 0.01).
Interestingly, β-casein-derived peptides are proline-rich
sequences, which are hardly hydrolyzed by gastrointestinal
enzymes (30). β-Lg-derived peptides belong to two protein
domains, namely the 42–57 and 125–135 regions, which are
known to survive the gastrointestinal digestion relatively well
(31–33). β-Lg f(125–135) is also partly translocated across
models of the intestinal epithelium, suggesting that it could
be up-taken and reach the portal blood circulation (34). β-Lg
f(42–57) and its shortened form, β-Lg f(42–54), were already
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TABLE 1 | LC-MS/MS-based identification of cow’s milk specific peptides in D samples.
Mass ([M+H]+) m/z* Charge Error (ppm) sequence bovine parent protein Uniprot PAN Position Samples
943.4886 472.2480 2 0.2 GGVSLPEWV α-lactalbumin P00711 19–27 D2
1117.5184 559.2626 2 −0.9 TPEVDDEALE β-lactoglobulin P02754 125–134 D3, D4, D5
1245.5844 623.2961 2 0 TPEVDDEALEK β-lactoglobulin P02754 125–135 D1, D3
1455.7210 728.3638 2 0.9 VEELKPTPEGDLE β-lactoglobulin P02754 43–55 D1, D3, D5
1681.8912 841.4492 2 1.0 VEELKPTPEGDLEIL β-lactoglobulin P02754 43–57 D3, D4, D5
1204.6100 602.8086 2 −0.1 YVEELKPTPE β-lactoglobulin P02754 42–51 D1, D3
978.5103 489.7588 2 −0.3 YVEELKPT β-lactoglobulin P02754 42–49 D3
1041.5438 521.2755 2 0.3 VEELKPTPE β-lactoglobulin P02754 43–51 D3
1108.6145 554.8112 2 −0.5 ENLLRFFVA αs1-casein P02662 18–26 D2, D3
964.4454 482.7266 2 −1.6 ESTVATLED κ-casein P02668 140–148 D3
1120.6379 560.8226 2 0.3 LPQNIPPLTQ β-casein P02666 70–79 D1, D3, D4, D5
1007.5517 504.2795 2 −0.3 PQNIPPLTQ β-casein P02666 71–79 D1, D3
882.4759 441.7418 2 0.6 QPLPPTVM β-casein P02666 149–156 D1, D2, D3, D4
1320.7497 660.8785 2 0.2 PVVVPPFLQPEV β-casein P02666 81–92 D2, D3, D4, D5
1221.6865 611.3469 2 0.1 PVVVPPFLQPE β-casein P02666 81–91 D1
1047.6558 524.3315 2 −0.3 VLPVPQKAVP β-casein P02666 170–179 D1
1024.4378 512.7228 2 0.8 ESPQTHYY lactoferrin P24627 86–93 D1, D2, D3
1021.4944 511.2511 2 −0.5 GSNFQLDQL lactoferrin P24627 101–109 D3, D4
1149.5528 575.2800 2 −0.6 GSNFQLDQLQ lactoferrin P24627 101–110 D3, D4
901.5460 451.2766 2 −0.5 VAVVKKGSN lactoferrin P24627 95–103 D4
1166.4905 583.7489 2 1.4 YEEYLGTEY lactoferrin P24627 657–665 D2, D4, D5
Error has been calculated after the MaxQuant re-calibration. *In the cases of peptides recurring in more than one sample, the m/z values are the closest to the theoretical ones.
TABLE 2 | Identification of cow’s milk specific peptides in T samples.
Mass ([M+H]+) m/z Charge Error (ppm) Sequence Bovine parent protein Uniprot PAN Position Samples
943.4874 472.2476 2 −1.1 GGVSLPEWV α-lactalbumin P00711 19–27 T3, T4
1204.6097 602.8084 2 −0.1 YVEELKPTPE β-lactoglobulin P02754 42–51 T1, T2
1117.5184 559.2626 2 −0.9 TPEVDDEALE β-lactoglobulin P02754 125–134 T1, T2, T3
1245.5843 623.2957 2 −0.1 TPEVDDEALEK β-lactoglobulin P02754 125–135 T1, T2, T3, T4
1108.6148 554.8113 2 −0.5 ENLLRFFVA αs1-casein P02662 18–26 T1, T2
784.4086 392.7082 2 −0.1 IESPPEI κ-casein P02668 153–159 T2
1120.6374 560.8223 2 1.1 LPQNIPPLTQ β-casein P02666 70–79 T1, T2
882.4680 441.7376 2 0.4 QPLPPTVM β-casein P02666 149–156 T2, T3, T4
1320.7497 660.8786 2 0.2 PVVVPPFLQPEV β-casein P02666 81–92 T1, T2, T3, T4
1840.9879 614.3341 3 0.1 LPPTVMFPPQSVLSLSQ β-casein P02666 151–167 T2, T3
identified in the breast milk of two lactating women in a
previous study (24). It is worth noting that a second donor
that had been initially enrolled in the study was excluded
because traces of cow’s milk peptides were found in her
control baseline breast milk, especially peptides derived from
β-casein. Upon specific inspection of the alimentary record,
we realized that she had inadvertently eaten dairy products
a few hours before milk collection. Importantly, the set of
exogenous peptides significantly changed among the different
samples at both qualitative and quantitative levels since some
of them recurred in several samples at varying intensity, while
others such as κ-casein f(140–148) appeared only once in sample
D3. Their size varied between 6 and 17 residues, although
longer fragments or whey proteins-derived S-S cross-linked
heterodimeric peptides escaping the MS identification might
have a chance of occurring as well.
Variability of the Peptide Profile
We traced the time course of the presence of peptides with dietary
origin in breast milk by analyzing the peptide fraction of samples
collected at several time points (samples T0–T5). The peptides
exclusive to cow’s milk detected in these breast milk samples
are listed in Table 2. Some of the peptides identified were the
same or belonged to the same protein regions detected in the D
samples, while others were exclusive of the two set of samples,
thus confirming the variability of exogenous species excreted into
breast milk.
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FIGURE 1 | Time course of the β-Lg f(125–135) (blue line) and β-casein
f(81–92) (red line) in breast milk, determined by the MS ion intensity of the
peptide signals in samples of the T series. Error bars are the standard
deviation of triplicate determinations.
To deduce the kinetics of the appearance and disappearance
of the dietary peptides in breast milk, we selected two sequences,
namely β-Lg f(125–135) and β-casein f(81–92), which were
detected over the longest time interval (T1–T4) and gave
the most abundant signals within the cow’s milk derived
components. After individuating the position of the peptides
along the chromatograms through the MS/MS fragmentation,
the proximate abundance of these peptides was estimated
by extracting the ions from the TIC chromatogram and
integrating the area of the MS signal from the full scan run,
at their specific retention time. These values were plotted
vs. time since the administration of bovine milk (Figure 1).
Dietary peptides were already detected at 1 h (T1) after the
consumption of cow’s milk and peaked after 2 h, whereas none
of them was detectable 6 h (T5) after the oral load. Perhaps,
carboxypeptidases mediated the time course of the conversion
of the peptide β-Lg (f125–135) into β-Lg (f125–134) upon
the removal of the C-terminal lysine. It was not possible
to monitor this conversion from a quantitative perspective
because the removal of the lysine residue significantly alters
the ionization efficiency of the peptides and also drastically
affects their fragmentation scheme. The MS/MS spectra of the
two peptides are compared in Figure 2, which evidences that
the y-series was prevalent in the fragmentation of β-Lg f(125–
135) (amino acid sequence: TPEVDDEALEK), whereas the b-
series dominated the fragmentation spectrum of β-Lg f(125–134)
(sequence: TPEVDDEALE).
For illustration, the identification workflow of the β-
casein f(81–92) is presented in Figure 3, which includes the
TIC chromatogram of the HPLC-MS/MS analysis relevant to
sample T2 (Figure 3A), the MS spectrum at 109.0–109.2min
(Figure 3B ), and the MS/MS fragmentation spectrum of the ion
m/z 660.8781 (Figure 3C). The inset of Figure 3B highlights the
very-low-intensity MS signal (ion intensity 2.71 × 106) of β-
casein f(81–92). In terms of the ion count, the dietary peptide
with the highest intensity, β-Lg f(125–135), did not exceed 6.1 ×
106, while average intensity of noise approached 4.0× 105.
Therefore, the signals of milk-derived peptides was at least
3.5–4 orders of magnitude (5 × 103-104-fold) less intense than
that of the most abundant endogenous peptides of breast milk
(intensity in the 1.7–2.9× 1010 range), which seriously challenges
the dynamic range of the MS method.
These findings demonstrated that peptides derived from the
maternal diet occurred at a very low abundance in comparison to
the endogenous peptides of breast milk, which in turn represent
only a fraction of the protein/polypeptide content of humanmilk.
The quantitative figures of this study represent a gross
estimation of the exogenous peptide abundances. An accurate
relative quantification among the T-series samples could be
achieved by labeling the peptides with stable-isotope tags
generating low-mass reporter fragments (e.g., iTRAQ method).
The absolute quantification of the dietary peptides would
require a dedicated study with appropriate standards and
should be performed sample-by-sample, due to the composition
variability of the polypeptide fraction of human milk (25).
In spite of the traditional classification of dietary proteins as
“fast” (whey proteins) and “slow” (caseins) based on their
relative digestion and absorption rates (34), the early-appearing
peptides arose from both caseins and whey proteins. This
suggests that hydrolytic fragments from the two protein families
could be rather quickly digested, distributed, and excreted into
breast milk.
Dot-Blot Analysis
β-Lg-derived peptides in the enriched and purified 12% TCA-
soluble peptide fraction of the D-series breast milk samples were
targeted by dot-blot analysis. Peptide extracts of all the samples
were clearly recognized by the anti-β-Lg antibody, similarly
to the chymotryptic digest of bovine whey proteins used as
the positive control (Figure 4). In contrast, the baseline breast
milk samples collected before the oral load of cow’s milk were
not immunoreactive, thereby excluding possible cross-reactivity
with peptides originating from endogenous milk proteins. The
intensity of the immunoreactive spots could not be correlated
to the number and ion intensity of the β-Lg-derived peptides
detected by HPLC-MS/MS because possible immunoreactive β-
Lg polypeptides might escape the MS analysis.
Competitive ELISA
In the attempt to quantify β-Lg peptides, we assayed all breast
milk samples with a competitive ELISA test that was specifically
developed to determine both native β-Lg and derived peptides in
processed food matrices. The standard β-Lg solutions fit a cubic
spline curve, in line with the manufacturer’s guidelines. None of
the breast milk samples contained detectable β-Lg peptides at the
declared limit of detection of 2.1 ppm, confirming our previous
results (24). The sensitivity of the competitive ELISA was most
likely inadequate to detect the β-Lg peptides, which plausibly
occurs at low ppb amounts according to a gross estimation based
on the relative MS signal intensities. Less diluted breast milk
samples (i.e., 1/50 and 1/100) assayed by ELISA gave inconsistent
results due to matrix interference. In general, ELISA-based
Frontiers in Nutrition | www.frontiersin.org 6 March 2019 | Volume 6 | Article 25
Picariello et al. Bovine Milk Peptides in Breast Milk
FIGURE 2 | Comparative MS/MS spectra of β-Lg f(125–135) and β-Lg f(125–134) in T2 sample. Matching fragments of the a-, b- and y-series have been assigned
using the Proteome Discoverer 2.1 software (Thermo Scientifics). The removal of the C-terminal Lys residue drastically alters the ionization efficiency and the
fragmentation scheme of the peptide.
methods can lead to false-positive and false-negative results when
applied to the determination of trace allergens in complex food
matrices, which emphasizes the need for analytical methods that
do not rely on antigen-antibody recognition (35).
Searching for Cow’s Milk Peptides in the
Protein Pellet
Dietary polypeptides in body fluids, especially blood or breast
milk, might be taken up by antibodies or associated with proteins
through non-specific interactions. Such an outcome might also
explain why the ELISA methods failed to detect those protein
fragments revealed by MS (26). In order to target possible intact
cow’s milk proteins or dietary peptides associated with carrier
antibodies or proteins in breast milk, the 12% TCA-insoluble
protein pellet was Cys-reduced/alkylated in denaturing buffer
(6M guanidine), and the resulting tryptic digests were analyzed
by HPLC-MS/MS. The database containing cow’s milk protein
sequences was searched using both trypsin cleavage specificity
or non-specific cleavage. On average, almost 400 endogenous
proteins per sample were identified with high confidence (1%
FDR, e < 0.01), which have already been described in human
milk (36, 37). However, no peptides ascribable to cow’s milk
proteins occurred in breast milk samples except for the β-
Lg f(125–135) peptide, albeit at trace amounts. This peptide
was detected by MS at very low intensity in only sample
D4. Most likely, the presence of this peptide fragment was
the result of an occasional non-specific association with breast
milk proteins.
Very recently, Zhu et al. (25) identified a set of cow’s milk-
derived peptides—especially from bovine αs1-casein—in all the
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FIGURE 3 | Exemplificative workflow for the identification of the peptide β-casein f(81–92) in the T2 breast milk sample. (A) HPLC MS/MS TIC chromatogram of the
12%TCA soluble peptides; (B) MS1 spectrum at retention time (RT) 109.0–109.2min. The inset in panel B shows a magnified view containing the m/z 660.88 signal
(*); (C) MS/MS spectrum of the m/z signal 660.88 with assignment of the β-casein f(81–92) signal fragments. The peptide of dietary origin is a minor MS signal
contained in a very low-abundance chromatographic peaks, so indicating its scant relative amount in breast milk.
analyzed human milk samples. Milk was sampled from mothers
who were not exposed to any dietary intervention. Based on the
identified peptides, the authors hypothesized the occurrence of
intact bovine αs1-casein in human milk, which is in line with
previous findings (21). However, the estimated level of intact
bovine αs1-casein (0.006 µg/µL) appears very high, even much
more than the value indicated as the upper amount reported so
far for dietary proteins in breast milk (3). In contrast, we were
not able to detect any of the bovine αs1-casein peptides generated
by tryptic digestion of the protein pellet, despite a careful visual
inspection of the LC-MS/MS runs (targeted ion extraction)
specifically aimed at detecting the sequences identified by Zhu
et al. (25) in all human milk samples analyzed. This finding
further supports the inter-individual variability of the excretion
of dietary peptides into breast milk.
Western Blotting for the Detection of
Intact β-Lg
The possible occurrence of dietary intact β-Lg was evaluated
by SDS-PAGE and parallel Western blot analysis (Figure 5).
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FIGURE 4 | Dot-blot detection of immunoreactive β-Lg peptides in the 12%
TCA soluble fraction of D-series breast milk samples. Baseline (BL) samples
were peptide extracts from breast milk obtained before the cow’s milk oral
load. H-β-Lg was a chymotryptic digest of β-Lg used as the positive control.
Interestingly, α-lactalbumin (14 kDa) and lactoferrin (76 kDa
excluding glycosylation) dominated the protein fraction of breast
milk samples. Intact caseins migrating at the apparent molecular
weight of 31 kDa appeared as minor bands in the SDS-PAGE
pattern, most likely due to extensive proteolysis. However, the
breast milk samples obtained from the different donor who was
excluded from the study (lanes E and E∗) exhibited more intense
bands of intact caseins, which confirms the great inter-individual
variability of the human milk protein fraction. A bovine whey
protein extract was used as the positive control, with estimated
amounts of β-Lg of 2 µg for the SDS-PAGE analysis and ∼20 pg
for the ECL reagent-based detection.
The estimated limit of detection of β-Lg by the Western
blot was abundantly below 1 pg (24). As expected, β-Lg was
clearly detected in the whey protein extract with both of the
analyses. In contrast, no band ascribable to intact β-Lg or derived
immunoreactive polypeptides was detected in any of the breast
milk samples. These findings confirmed the substantial absence
of intact β-Lg in the analyzed samples.
DISCUSSION
The findings of this study confirmed our previous outcomes
suggesting that dietary peptides rather than intact allergens
could be excreted into breast milk (24). This work has
enlarged our previous repertoire of cow’s milk-derived peptides
in breast milk, which included the analysis of human milk
samples obtained from 12 donors. The peptide sequences
identified were relatively short and, therefore, their effective
involvement in the immune response is questionable. On the
other hand, there is a possible occurrence of additional large-
sized protein fragments or even whey protein-derived disulfide
cross-linked peptides, which are hardly evidenced by MS-
based methods. To this purpose, T2 probably contained a 30-
residue-long bovine κ-casein peptide, namely κ-casein f(135–
165), which was identified by the search engine with a relatively
low identification score. This peptide was not included in
Table 2, because the MS/MS did not contain a pattern of
fragment ions sufficient for a definitive attribution, though
the measured molecular weight matched the theoretical one
(1mass< 1 ppm).
The panel of cow’s milk peptides appeared strongly variable
in the milk of a single donor, which was collected on several
days as well as over a 6-h time course. These observations
should be confirmed by extending the study to a higher
number of samples. Unfortunately, only a handful of lactating
mothers agreed to enroll in such a study, and the milk
of only a few of them contained detectable cow’s milk-
derived peptides. Consistently, β-Lg has been reported to occur
in 62.5 (38) or 75% (39) of milk samples from a small
cohort of lactating mothers, which showed the appearance and
disappearance as well as the variability of abundance over the
15-h sampling.
The presence of dietary peptides in breast milk provides
indirect evidence that fragments of food proteins can survive
the gastrointestinal digestion, pass into the bloodstream, and
distribute to peripheral organs. The inter- and intra-individual
variability has already been reported by several studies, although
they were carried out by immunochemical methods in terms
of the excretion of intact allergens or derived large-sized
polypeptides into breast milk (2, 14, 39, 40). The contributions
of various factors to the fluctuation and to kinetics appearance
of dietary peptides in breast milk remain to be established, such
as inherent variable digestion capacity, the co-consumption of
other foods and their structure, altered intestinal permeability,
and transitory leakage at the level of the mammary epithelium.
The clinically evident adverse reactions of predisposed
newborns to food ingested by the mother represents proof that
dietary peptides in breast milk are immunologically active. It
has been amply demonstrated that upon the mother’s abstinence
from milk and dairy products, atopic manifestations against
cow’s milk proteins in previously sensitized breastfed infants
disappear (9). On the other hand, the onset of cow’s milk
allergy in infants is not correlated with the presence of bovine
proteins in breast milk (9, 38, 41). Although capable of eliciting
allergic reactions, it is not known whether the small amounts
of food antigens present in maternal milk contribute to prime
sensitization or whether sensitization occurs upon exposure
through different routes (chiefly the skin). In fact, many children
with food allergies experience their first adverse reaction upon
the first known ingestion of the offending food, indicating that
a previous occult sensitization had occurred. In this work, we
did not detect large cow’s milk-derived polypeptides or intact
proteins in breast milk. This finding contrasts with part of
the previous literature (20, 21). However, on the basis of our
results, we can exclude that very tiny amounts of undigested
allergens might be excreted into breast milk. The very rapid
appearance of food allergens in the mother’s biological fluids,
including blood and breast milk has been explained with an
uptake through the skin or oral mucosa, which also would justify
the very rapid onset of allergy symptoms in some breastfed
newborns (13). Nevertheless, the evidences that dietary proteins
could reach undigested the biological fluids are still weak. It
has been suggested that food allergens might be processed and
degraded at the lysosomal level by mucosal cells before being
adsorbed and distributed (42). Supposedly, the predominance
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FIGURE 5 | SDS-PAGE electrophoresis (upper panels) and anti-β-Lg Western blotting (lower panels) of protein pellets from D1–D5 and T0–T5 breast milk samples. D
samples were collected before (w/out*) and after (*) a baby’s suck. E samples are from the donor excluded from the study. Bovine whey proteins were the β-Lg
positive control. For the Western blotting analysis, the estimated amount of β-Lg in the control was 20 pg. Lf, lactoferrin; β-Lg, β-lactoglobulin; α-La, α-lactalbumin.
of the skin or gastrointestinal penetration routes of dietary
antigen might also depend on nature of a meal or structure of
the food. For example, peanuts must be chewed, while milk is
quickly swallowed and has a very short time of persistent contact
with the oral mucosa. Regardless, the effect of breastfeeding
on the development of adverse reactions to foods or allergic
diseases in newborns is still controversial, substantially because
the mechanisms regulating the thin boundaries between the
acquisition of tolerance and sensitization to food allergens
in early infanthood are still poorly defined. Breastfeeding
has commonly recognized protective effects against allergenic
manifestations in children, especially those with a familial atopy
(43, 44). However, these effects are still debated in the context
of food allergies. Recent evidence indicates that the route of
exposure to food allergens in early life has a key role in
determining sensitization or oral tolerance (45). In particular,
the low amount of foreign antigenic proteins in breast milk
seems to be tolerogenic rather than causing early sensitization to
food allergens. This suggests that lactating mothers should not
observe an elimination diet during pregnancy and lactation as a
strategy to prevent childhood allergies in newborns who are at
risk of atopy.
CONCLUSIONS
Breast milk could contain trace amounts of peptides resulting
from the digestion of dietary proteins eaten by the lactating
mother. The profile of cow’s milk-derived peptides in breast
milk after the mother consumes cow’s milk appears affected by
inter- and intra-individual variability. The plausible content of
the food-derived peptides varies within the ppb range or less,
and their identification was possible only upon enrichment of
the peptide fraction of breast milk and high-resolution/sensitivity
MS-based analysis. Dot-blot using anti-bovine β-Lg antibody
also revealed traces of β-Lg in the TCA-soluble fraction after
peptide enrichment. In contrast, no intact cow-milk protein
allergens were detected in the breast milk. The presence of
dietary peptides suggests that the analytical perspective should be
shifted with respect to the large number of studies reporting on
the immunochemical detection of intact dietary food allergens
in breast milk. However, the possibility that large-sized food-
derived polypeptides occur in breast milk cannot be ruled
out. The eventual amount of these foreign polypeptides might
be out of reach for common immunoassays (such as ELISA)
when applied to unfractionated breast milk. The possible
sensitization/elicitation potential or the tolerogenic properties of
such low amounts of dietary peptides remain to be explored.
Similarly, the accurate quantification of exogenous peptides
in breast milk should be performed with properly designed
quantitative proteomic techniques, over a large number of
lactating mothers.
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